Home › Crohn's Disease › Alabama › Dothan
Crohn's Disease clinical trials in Dothan, AL
5 studies for Crohn's Disease are looking for participants at sites in and around Dothan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Digestive Health Specialists /ID# 280827, Dothan
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecruitingPhase 2
- Digestive Health Specialists /ID# 266216, Dothan
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Digestive Health Specialists of the Southeast, Dothan
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Digestive Health Specialists, Dothan
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RecruitingPhase 4
- Digestive Health Specialsits, Dothan
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
Other studies in Dothan
- Obesity4 studies
- Overweight3 studies
- Ulcerative Colitis3 studies
- Schizophrenia3 studies
- Atrial Fibrillation3 studies
- Blood Clots3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.